The ACC has begun submitting fiscal year 2022 appropriations requests for increases in cardiovascular disease research and prevention funding at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). These requests align with the American Heart Association, the Campaign for Tobacco-Free Kids, and Conquering CHD recommendations for heart and stroke programs, tobacco cessation and prevention and congenital heart disease research.

These programs have long been championed by the National Coalition for Heart and Stroke Research, are most closely aligned with ACC's Mission, and will help advance efforts to address health disparities. The funding numbers are based on a series of factors: meaningful growth above inflation, the top policy priorities of Appropriations Committee chairs and ranking members, as well as the program's funding history and vulnerability to cuts.

Agency/Program	FY21 Funding Level	FY22 Request
National Heart, Lung, and Blood Institution (NHLBI)	$3.664 billion	$3.963 billion
CDC Division for Heart Disease and Stroke	$143 million	$160 million
CDC WISEWOMAN	$28 million	$46.7 million
CDC Million Hearts	$4 million	$10 million
CDC Congenital Heart Disease Research	$7 million	$10 million
CDC Office on Smoking and Health	$237.5 million	$310 million

Read last year's requests here.

Clinical Topics: Congenital Heart Disease and Pediatric Cardiology, Congenital Heart Disease

Keywords: ACC Advocacy, American Heart Association, Tobacco Use Cessation, Tobacco Use, Tobacco, National Institutes of Health (U.S.), Heart Defects, Congenital, Centers for Disease Control and Prevention, U.S., Stroke

< Back to Listings